| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |